Thoracic medical oncologist · LMU Klinikum München · Germany (DE) · Oncology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
3 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 25 Jul 2026 | Investigator meeting | Virtual | Rachel Adeyemi | Vantrexa | Elderly / ECOG 2 patientsPD-L1 testing turnaround | 0 | — | Reviewed | ENG-0073 |
| 27 May 2026 | Medical education | Virtual | Rachel Adeyemi | Vantrexa | Duration of response | 0 | — | Reviewed | ENG-0013 |
| 22 Apr 2026 | Medical education | Phone | Rachel Adeyemi | Vantrexa | PD-L1 testing turnaroundElderly / ECOG 2 patients+1 | 0 | — | Reviewed | ENG-0034 |
| 24 Feb 2026 | Scientific exchange | In person | Rachel Adeyemi | Vantrexa | Duration of responseChemotherapy-free first line+1 | 0 | MI request | Reviewed | ENG-0042 |
25 Jul 2026
Elderly / ECOG 2 patients, PD-L1 testing turnaround
27 May 2026
Duration of response
22 Apr 2026
PD-L1 testing turnaround, Elderly / ECOG 2 patients, Brain-metastasis subgroup data
24 Feb 2026
Duration of response, Chemotherapy-free first line, Comparator checkpoint monotherapy
LMU Klinikum München
Radiation oncologist
Thoracic medical oncologist
Academic nephrologist
Community nephrologist
Headache specialist
Allergist
Dermatologist
Allergist